Tag: pharmaceuticals
-
Engineered Insulin-Producing Cells to Be Grown in Lab
A team from three universities is developing in the lab synthetic islet cells, the cells that produce insulin in the pancreas, for eventual transplantation in people with type 1 diabetes.
-
Vaccines in Development for Opioid Combinations
Researchers studying the immune system as a weapon against opioid addiction say they can develop vaccines that block combinations of opioids, like those sold on the street.
-
Study Testing Repurposed Drugs with Resistant Bacteria
A university team is investigating two current drug compounds for their ability to take on a new task, fighting bacteria becoming resistant to antibiotics.
-
AstraZeneca, Biotech Partner on Messenger RNA Therapies
Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments.
-
Trial Testing Engineered Virus as Cancer Treatment
A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers.
-
Parkinson’s Protein Experiment in Space Station Cargo
An experiment to grow a crystallized form of protein associated with Parkinson’s disease is among the cargo that lifted off today from NASA’s Kennedy Space Center.
-
Patent Set for Peptide Nerve Damage Treatments
The European Patent Office announced its intent to award a patent on treatments for nerve cell damage based on the peptide thymosin beta 4.
-
Viruses Removed from Pig Organs for Human Transplants
Researchers in the U.S., Denmark, and China devised a process with genome editing to remove viruses that prevent organs from pigs from being used for human transplants.
-
Peptide Immunotherapy Shown Safe for Type 1 Diabetes
In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes.
-
Trial Underway Testing New ALS Treatment
Patients in a clinical trial testing a treatment for amyotrophic lateral sclerosis, or ALS, began receiving their first doses administered by the study team.